{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:12:23Z","timestamp":1792131143943,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001381","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF-CRP25-2020-0003"],"award-info":[{"award-number":["NRF-CRP25-2020-0003"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001869-00"],"award-info":[{"award-number":["MOH-001869-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001271-00"],"award-info":[{"award-number":["MOH-001271-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128510","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:50:08Z","timestamp":1774338608000},"page":"128510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humans"],"prefix":"10.1016","volume":"79","author":[{"given":"Justin S.G.","family":"Ooi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Zayanah","family":"Hamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwee Cheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Xin","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie S.Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey Ming Er","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia Z.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan Rong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rivino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny G.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Eong","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Kalimuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10441","key":"10.1016\/j.vaccine.2026.128510_bb0005","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","article-title":"Contribution of vaccination to improved survival and health: modelling 50 years of the expanded programme on immunization","volume":"403","author":"Shattock","year":"2024","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128510_bb0010","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128510_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"7891","key":"10.1016\/j.vaccine.2026.128510_bb0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41586-021-04186-8","article-title":"Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2","volume":"601","author":"Swadling","year":"2022","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.vaccine.2026.128510_bb0025","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170011","article-title":"Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults","volume":"133","author":"Samandari","year":"2023","journal-title":"J Clin Invest"},{"issue":"16","key":"10.1016\/j.vaccine.2026.128510_bb0030","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMc2036242","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"384","author":"Skowronski","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128510_bb0035","article-title":"Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset","volume":"2","author":"Kalimuddin","year":"2021","journal-title":"Med N Y"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128510_bb0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood.2022016166","article-title":"Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell-treated patients","volume":"140","author":"Oh","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128510_bb0045","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41591-024-02962-3","article-title":"Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children","volume":"30","author":"Zhong","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128510_bb0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41564-024-01903-7","article-title":"Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans","volume":"10","author":"Kalimuddin","year":"2025","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128510_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(25)00382-2","article-title":"Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in Sao Paulo, Brazil: a test-negative, case-control study","volume":"26","author":"Ranzani","year":"2026","journal-title":"Lancet Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2026.128510_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152379","article-title":"Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals","volume":"131","author":"Tan","year":"2021","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128510_bb0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128510_bb0070","first-page":"1033","article-title":"Activation and kinetics of circulating T follicular helper cells, specific Plasmablast response, and development of neutralizing antibodies following yellow fever virus vaccination","volume":"207","author":"Sandberg","year":"2021","journal-title":"J Immunol (Baltimore, Md\u202f: 1950)"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128510_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149871","article-title":"A single 17D yellow fever vaccination provides lifelong immunity; characterization of yellow-fever-specific neutralizing antibody and T-cell responses after vaccination","volume":"11","author":"Wieten","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128510_bb0080","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1073\/pnas.1921388117","article-title":"Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine","volume":"117","author":"Wec","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2026.128510_bb0085","doi-asserted-by":"crossref","first-page":"16164","DOI":"10.1038\/nmicrobiol.2016.164","article-title":"Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity","volume":"1","author":"Chan","year":"2016","journal-title":"Nat Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128510_bb0090","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41590-022-01328-6","article-title":"Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses","volume":"23","author":"Hagan","year":"2022","journal-title":"Nat Immunol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2026.128510_bb0095","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cca.2011.11.006","article-title":"Surface markers of lymphocyte activation and markers of cell proliferation","volume":"413","author":"Shipkova","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128510_bb0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005512","article-title":"The LAT story: a tale of cooperativity, coordination, and choreography","volume":"2","author":"Balagopalan","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128510_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2012.03591.x","article-title":"Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity","volume":"137","author":"Stanford","year":"2012","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128510_bb0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00011-017-1032-8","article-title":"The immunological function of CD52 and its targeting in organ transplantation","volume":"66","author":"Zhao","year":"2017","journal-title":"Inflamm Res"},{"key":"10.1016\/j.vaccine.2026.128510_bb0115","series-title":"Negative co-receptors and ligands","first-page":"17","article-title":"Role of PD-1 in regulating T-cell immunity","author":"Jin","year":"2011"},{"key":"10.1016\/j.vaccine.2026.128510_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.679739","article-title":"The GIMAP family proteins: an incomplete puzzle","volume":"12","author":"Limoges","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128510_bb0125","article-title":"Comprehensive pan-cancer analysis of PTGES3 and its prognostic role in hepatocellular carcinoma","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"issue":"7872","key":"10.1016\/j.vaccine.2026.128510_bb0130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128510_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-0-387-34814-8_3","article-title":"Understanding the role of innate immunity in the mechanism of action of the live attenuated yellow fever vaccine 17D","volume":"590","author":"Querec","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128510_bb0140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2026.128510_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2016.01.002","article-title":"The development of therapeutic antibodies against dengue virus","volume":"128","author":"Fibriansah","year":"2016","journal-title":"Antivir Res"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128510_bb0150","first-page":"7919","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol (Baltimore, Md\u202f: 1950)"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128510_bb0155","doi-asserted-by":"crossref","DOI":"10.4110\/in.2023.23.e33","article-title":"SARS-CoV-2 mRNA vaccine elicits sustained T cell responses against the omicron variant in adolescents","volume":"23","author":"Choi","year":"2023","journal-title":"Immune Netw"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128510_bb0160","article-title":"Durability of immune responses to mRNA booster vaccination against COVID-19","volume":"133","author":"Suthar","year":"2023","journal-title":"J Clin Invest"},{"issue":"6608","key":"10.1016\/j.vaccine.2026.128510_bb0165","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1126\/science.add2897","article-title":"T cell immunity to COVID-19 vaccines","volume":"377","author":"Wherry","year":"2022","journal-title":"Science (New York, NY)"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128510_bb0170","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/s41590-023-01613-y","article-title":"Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection","volume":"24","author":"Painter","year":"2023","journal-title":"Nat Immunol"},{"issue":"829","key":"10.1016\/j.vaccine.2026.128510_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ads5932","article-title":"Distinct systemic immune responses in asymptomatic and symptomatic dengue virus infection","volume":"17","author":"Sungnak","year":"2025","journal-title":"Sci Transl Med"},{"issue":"405","key":"10.1016\/j.vaccine.2026.128510_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal5088","article-title":"Increased adaptive immune responses and proper feedback regulation protect against clinical dengue","volume":"9","author":"Simon-Loriere","year":"2017","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128510_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2025.06.006","article-title":"Immune profiling in subclinical secondary dengue-infected cases reveals adaptive immune signatures correlated to protection from severe dengue","volume":"33","author":"Gonnella","year":"2025","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128510_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002351","article-title":"Minding the \u201cT\u201ds beyond the \u201cB\u201ds: shaping vaccines for future pandemics","volume":"21","author":"Kalimuddin","year":"2023","journal-title":"PLoS Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128510_bb0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12916-022-02252-0","article-title":"Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2","volume":"20","author":"Ukey","year":"2022","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128510_bb0200","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41541-022-00573-y","article-title":"Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine","volume":"7","author":"Ong","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"704","key":"10.1016\/j.vaccine.2026.128510_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh3067","article-title":"Insights into dengue immunity from vaccine trials","volume":"15","author":"Ooi","year":"2023","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128510_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128510_bb0215","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1073\/pnas.1500475112","article-title":"Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination","volume":"112","author":"Akondy","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128510_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001643","article-title":"Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes","volume":"20","author":"Syenina","year":"2022","journal-title":"PLoS Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128510_bb0225","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128510_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128510_bb0235","article-title":"Thirteen years of clusterProfiler","volume":"5","author":"Yu","year":"2024","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.vaccine.2026.128510_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1135979","article-title":"An experimental medicine decipher of a minimum correlate of cellular immunity: study protocol for a double-blind randomized controlled trial","volume":"14","author":"Kalimuddin","year":"2023","journal-title":"Front Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600318X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600318X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:48:10Z","timestamp":1781308090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2600318X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"alternative-id":["S0264410X2600318X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128510","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humans","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128510"}}